Cytosorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses.
| Website: | www.cytosorbents.com |
| Email: | info@medasorb.com |
| Main Phone: | +1 732 329-8885 |
| Address: | 7 Deer Park Drive |
| Address 2: | Suite K |
| State: | NJ |
| City / Town: | Monmouth Junction |
| Country: | USA |
| Postal Code: | 08852 |
| Exchange: | NSC |
| Employees: | 57 |
| NAICS: | Medical Laborato |
| Last Price 7.90 | Change $ -0.2 | Change % -2.47 | Tick N/A |
| Bid 7.85 | Bid Size 900.00 | Ask 7.90 | Ask Size 200.00 |
| Open 8.05 | High 8.10 | Low 7.80 | Prev Close 8.10 |
| Last Trade | Volume 91,347 | 52 Wk Hi 8.35 | 52 Wk Low 3.30 |
| Market Cap 232.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 29,471,343.00 | EPS (TTM) -0.27 | PE Ratio N/A | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 13 | 35 |
| Number of Buys | 13 | 26 |
| Number of Sells | 0 | 9 |
| Net Activity | 308000 | 313592 |
| Last 10 Buys | Shares |
|---|---|
| Michael G. Bator | 1,000 |
| Kathleen P. Bloch | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Vincent Capponi | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Al Kraus | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 24 | 24 | 24 | 24 |
| Low Target Price Estimate | 8 | 8 | 8 | 8 |
| Mean Target Price Estimate | 14.63 | 14.63 | 14.63 | 13.8 |
| Standard Deviation | 5.76 | 5.76 | 5.76 | 6.03 |
| Date of Most Recent Estimate | 08/12/16 | 06/02/16 | 06/02/16 | 08/19/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2016-08-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 57 | 2016-08-09 |
| 8-K | Report of unscheduled material events or corporate changes. | 47 | 2016-07-01 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.25 | 1.2 | 1.2 | 1.2 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
